Company: SCLXW
Filing Date: 2025-10-28
Form Type: PRE 14A
Source: 0001193125-25-253884
Chunk: 3

Company: Scilex Holding Co
Filing Date: 2025-10-28
Form: PRE 14A
Chunk 3
---
 of the Special Meeting to approve the Option Repricing Proposal (the “Adjournment Proposal”). |

How does the Board recommend I vote on the proposal? Our Board recommends a vote:

| • |     | “FOR” the approval of the Option Repricing Proposal; and |

| • |     | “FOR” the approval of the Adjournment Proposal. |

What if another matter is properly brought before the meeting? Our Board knows of no other matters that will be presented for consideration at the Special Meeting. Our bylaws (our “Bylaws”) provide that business transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or purposes stated in the notice of the meeting and only the Option Repricing Proposal and the Adjournment Proposal are stated in the Notice of Special Meeting of Stockholders accompanying this proxy statement. Our Bylaws also provide that stockholders shall not be permitted to propose business to be brought before a special meeting of the stockholders. Who is entitled to vote? Holders of our common stock, par value $0.0001 per share (“Common Stock”), and holders of our Series A preferred stock, par value $0.0001 per share (“Series A Preferred Stock”), as of the close of business on 1

November 3, 2025, the record date for the Special Meeting (the “Record Date”), may vote at the Special Meeting. The holders of Series A Preferred Stock are entitled to vote, together with the holders of Common Stock and not separately as a class, on an as converted to Common Stock basis, on all matters on which the holders of shares of Common Stock have the right to vote. As of the Record Date, there were shares of our Common Stock and 29,057,097 shares of Series A Preferred Stock outstanding. Each share of Common Stock is entitled to one vote on each proposal. The 29,057,097 shares of Series A Preferred Stock outstanding are entitled to a number of votes as determined by dividing the stated value (as determined under our Certificate of Designations of Series A Preferred Stock, filed with the Delaware Secretary of State on November 10, 2022 (the “Certificate of Designations”)) by $10.00 and, as of the Record Date, such preferred stock is entitled to an aggregate of votes as a result of adjustments to the deemed conversion price of such preferred stock in accordance with the terms of the Certificate of Designations. The shares of Common Stock and Series A Preferred Stock are the only shares of